Secukinumab - PDFSEARCH.IO - Document Search Engine

Secukinumab
Results: 8

#	Item
1	438150This information is intended for UK medical media only 00This information is intended for UK medical media only MEDIA RELEASE • MEDIA RELEASE • MEDIA RELEASE CosentyxTM (secukinumab),▼the first IL- Add to Reading List Source URL: preview.thenewsmarket.com Language: English - Date: 2015-05-29 06:55:23 Pharmacology Monoclonal antibodies Centocor Health Ustekinumab Psoriatic nails Etanercept Psoriatic arthritis Biologic Immunosuppressants Psoriasis Medicine
2	Microsoft Word - TB-CUPrestatie- en tariefbeschikking add-on secukinumab.docx Add to Reading List Source URL: www.nza.nl Language: Dutch - Date: 2015-03-06 05:07:00
3	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2015-05-13 10:22:20 National Psoriasis Foundation Psoriatic arthritis Secukinumab Biologic Generalized pustular psoriasis Light therapy Mark G. Lebwohl Psoriasis Medicine Health
4	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2015-05-13 10:22:08 Arthritis Rheumatology Immunosuppressants Psoriasis Rheumatoid arthritis Ankylosing spondylitis Psoriatic nails Psoriatic arthritis Secukinumab Medicine Health Autoimmune diseases
5	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Blvd. Dorval, Quebec Canada H9S 1A9 www.novartis.ca Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2015-05-13 10:22:14 Health Autoimmune diseases Arthritis Monoclonal antibodies Ustekinumab Etanercept National Psoriasis Foundation Secukinumab Biologic Psoriasis Immunosuppressants Medicine
6	Novartis International AG Novartis Global Communications CH-4002 Basel Switzerland http://www.novartis.com Add to Reading List Source URL: hugin.info Language: English - Date: 2014-10-20 13:14:43 Health Immunology Monoclonal antibodies Secukinumab National Psoriasis Foundation Novartis Psoriatic arthritis Light therapy Biologic Psoriasis Medicine Immunosuppressants
7	Secukinumab (AIN457) ADVISORY COMMITTEE BRIEFING MATERIAL: AVAILABLE FOR PUBLIC RELEASE Prepared by Novartis Pharmaceuticals Corporation for the Add to Reading List Source URL: www.fda.gov Language: English Psoriasis Health Monoclonal antibodies Etanercept Placebo Ustekinumab Infliximab Medicine Immunosuppressants Pharmacology
8	Novartis Pharmaceuticals Canada Inc. 385 Bouchard Boulevard Dorval, Quebec H9S 1A9 www.novartis.ca http://www.novartis.com Add to Reading List Source URL: www.novartis.ca Language: English - Date: 2014-11-17 07:51:08 Medicine Pharmacology Secukinumab Etanercept Novartis Tumor necrosis factor-alpha Generalized pustular psoriasis Goeckerman Therapy Immunosuppressants Immunology Psoriasis